Fruzaqla
These highlights do not include all the information needed to use FRUZAQLA safely and effectively. See full prescribing information for FRUZAQLA. FRUZAQLA (fruquintinib) capsules, for oral use Initial U.S. Approval: 2023
186d786e-dc8a-45f2-b5e1-01ac0201879f
HUMAN PRESCRIPTION DRUG LABEL
Dec 21, 2023
Takeda Pharmaceuticals America, Inc.
DUNS: 039997266
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
fruquintinib
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (8)
fruquintinib
Product Details
FDA regulatory identification and product classification information